glp-1 kidney news receptor agonists and next-generation metabolic hormone therapies in chronic disease GLP-1 and the kidney: from

But for the major therapeutic peptides used in aesthetic and longevity protocols, injectable delivery is the baseline for reliable results

Whilst prevalence of its self-directed use is difficult to calculate accurately, there is evidence of significantly increased use amongst IPED users in the UK (Evans-Brown & McVeigh, 2009a, Begley et al, 2017)

Ascorbyl glucoside and ascorbyl tetraisopalmitate These are stabilised, oil or water-soluble derivatives of vitamin c

Its activity reflects coordinated communication between hypothalamus, pituitary, and peripheral tissues

Back Brandt, SJ, Mller, TD, DiMarchi, RD, et al (12 Sept 2018) 'Peptide-based multi-agonists: a new paradigm in metabolic pharmacology', Journal of Internal Medicine